LARRY SPRUNG: Open Payments
NPI 1447278940 · GLENDALE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,092 in 55 payments from 11 companies in 2025. Trend: 2023 $172 · 2024 $999 · 2025 $1,092
Food & beverage: $1,092
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $323 |
| ABBVIE INC. | 15 | $195 |
| Lundbeck LLC | 6 | $133 |
| Neurocrine BioSciences, Inc. | 6 | $116 |
| Axsome Therapeutics, Inc. | 5 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
| Corium, LLC | 3 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
Products named: REXULTI, VRAYLAR, INGREZZA, Auvelity, CAPLYTA, AUSTEDO XR, Azstarys, TRINTELLIX.
Industry payments across WI — which companies pay providers there.
